Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 1
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives.
Smeijsters EH, van der Elst KCM, Visch A, Göbel C, Loeff FC, Rispens T, Huitema ADR, van Luin M, El Amrani M. Smeijsters EH, et al. Among authors: gobel c. Pharmaceutics. 2023 May 12;15(5):1477. doi: 10.3390/pharmaceutics15051477. Pharmaceutics. 2023. PMID: 37242719 Free PMC article.
Quantification of neutralizing anti-drug antibodies and their neutralizing capacity using competitive displacement and tandem mass spectrometry: Infliximab as proof of principle.
El Amrani M, Göbel C, Egas AC, Nierkens S, Hack CE, Huitema ADR, van Maarseveen EM. El Amrani M, et al. Among authors: gobel c. J Transl Autoimmun. 2019 May 28;1:100004. doi: 10.1016/j.jtauto.2019.100004. eCollection 2019 Apr. J Transl Autoimmun. 2019. PMID: 32743494 Free PMC article.
Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method.
El Amrani M, van den Broek MP, Göbel C, van Maarseveen EM. El Amrani M, et al. Among authors: gobel c. J Chromatogr A. 2016 Jul 8;1454:42-8. doi: 10.1016/j.chroma.2016.05.070. Epub 2016 May 22. J Chromatogr A. 2016. PMID: 27264745